Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$104.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medicinova announces positive results of MN-001 in Advanced NASH Mouse Model


Tuesday, 5 Aug 2014 07:30am EDT 

Medicinova Inc:Says positive results from a second preclinical study that examined the potential clinical efficacy of MN-001 for the treatment of advanced NASH (nonalcoholic steatohepatitis with fibrosis).Study used mice in more advanced stages of NASH as compared to the first study of MN-001 in a NASH mouse model. 

Company Quote

452.0
25.0 +5.85%
2:00am EDT